Form 4: QuidelOrtho Director Kenneth F. Buechler Reports Stock Transactions
SEC Form 4 Filing
Director Kenneth F. Buechler reports the release of restricted stock units resulting in the acquisition of QuidelOrtho Corp common stock.
Summary
- On May 12, 2024, Kenneth F. Buechler, a director of QuidelOrtho Corp, reported transactions involving common stock.
- The transactions involved the release of restricted stock units, which were previously reported on a Form 4.
- These restricted stock units represent the right to receive one share of QuidelOrtho Corporation common stock.
- 506 shares of common stock were acquired at a price of $0, increasing the holdings to 84,185 shares.
- An additional 151 shares of common stock were acquired at a price of $0, further increasing the holdings to 84,336 shares.
- The release of restricted stock units was deferred under QuidelOrtho's deferred compensation program for non-employee directors and occurred according to the elected deferred schedule.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions related to deferred compensation. While increased ownership is generally positive, it's not a market-moving event in this context.
Positives
- The director's increased stock ownership could be interpreted as a positive sign of confidence in the company's future.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Comparing insider transactions to those of directors at similar diagnostic companies like Abbott Laboratories (ABT) or Danaher Corporation (DHR) can provide context.
- However, the significance of these transactions depends on the individual circumstances and compensation structures of each company.
- For example, a similar release of restricted stock units at Abbott or Danaher might involve different quantities of shares and have varying impacts on the director's overall holdings.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it signals confidence from a director.
- There is no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 05/12/2024 | Date of the reported transactions (release of restricted stock units). |
| 05/14/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.